Author: Hak, E.; Hoes, A. W.; Grobbee, D. E.; Lammers, J. W. J.; van Essen, G. A.; van Loon, A. M.; Verheij, T. J. M.
Title: Conventional Influenza Vaccination Is Not Associated with Complications in Working-Age Patients with Asthma or Chronic Obstructive Pulmonary Disease Cord-id: 7goz1agp Document date: 2003_4_15
ID: 7goz1agp
Snippet: By using a nested case-control design, the authors studied the effectiveness of the influenza vaccine in reducing severe and fatal complications in 4,241 and 5,966 primary care, working-age patients aged 18–64 years who had asthma or chronic obstructive pulmonary disease during the 1998–1999 and 1999–2000 influenza epidemics in the Netherlands. Patients developing fatal or nonfatal exacerbations of lung disease, pneumonia, congestive heart failure, or myocardial infarction during either ep
Document: By using a nested case-control design, the authors studied the effectiveness of the influenza vaccine in reducing severe and fatal complications in 4,241 and 5,966 primary care, working-age patients aged 18–64 years who had asthma or chronic obstructive pulmonary disease during the 1998–1999 and 1999–2000 influenza epidemics in the Netherlands. Patients developing fatal or nonfatal exacerbations of lung disease, pneumonia, congestive heart failure, or myocardial infarction during either epidemic were considered cases. For each case, four age- and sex-matched controls were randomly sampled, and patient records were reviewed. Conditional logistic regression and propensity scores were used to assess vaccine effectiveness after adjustment for confounding factors. In seasons one and two, respectively, 87% (47/54) and 85% (171/202) of the cases and 74% (155/210) and 75% (575/766) of the controls had been vaccinated. After adjustments, vaccination was not associated with reductions in complications (season one: odds ratio = 0.95, 95% confidence interval (CI): 0.26, 3.48; season two: odds ratio = 1.07, 95% CI: 0.59, 1.96; pooled odds ratio = 1.07, 95% CI: 0.63, 1.80). Because influenza vaccination appeared not to be associated with a clinically relevant reduction in severe morbidity, other measures need to be explored.
Search related documents:
Co phrase search for related documents- absence presence and additional risk factor: 1
- absence presence and adjusted odd: 1
- absence presence and adjusted odd ratio: 1
- absence presence and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- absence presence and logistic regression analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- absence presence and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- academic network and acute respiratory illness: 1, 2
- academic network and logistic regression: 1, 2, 3
- academic network and logistic regression analysis: 1
- acute cardiac disease and lung disease: 1, 2
- acute respiratory illness and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory illness and logistic regression analysis: 1, 2, 3, 4, 5
- acute respiratory illness and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- additional risk factor and logistic regression: 1, 2, 3, 4
- additional risk factor and logistic regression analysis: 1, 2
- additional risk factor and lung disease: 1, 2
- adjusted odd and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- adjusted odd and logistic regression analysis: 1, 2, 3
- adjusted odd ratio and logistic regression analysis: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date